Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
As of today, Apellis Pharmaceuticals(APLS) shares are valued at $40.68. The company's market cap stands at 5.2B, with a P/E ratio of 235.67.
On 2026-04-07, Apellis Pharmaceuticals(APLS) stock traded between a low of $40.55 and a high of $40.77. Shares are currently priced at $40.68, which is +0.3% above the low and -0.2% below the high.
Apellis Pharmaceuticals(APLS) shares are trading with a volume of 2.51M, against a daily average of 15.06M.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $40.77 and a 52-week low of $16.10.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $40.77 and a 52-week low of $16.10.
APLS News
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) shares experienced a sharp reversal as the stock’s momentum score jumped from 8.36 to 95.26 on a week-over-week basis...
Apellis Pharmaceuticals, Inc. (APLS) shares rallied 135.4% in the last trading session to close at $40.23. This move can be attributable to notable volume with...
J.P. Morgan analyst Anupam Rama has maintained their neutral stance on APLS stock, giving a Hold rating today. End of Quarter Sale - 50% Off TipRanks Unlock hed...
Analyst ratings
90%
of 21 ratingsMore APLS News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.